RESPOTIL DIN 02513811
Status: Marketed
Holder: MODERN VETERINARY THERAPEUTICS LLC
Molecule: TILMICOSIN (TILMICOSIN PHOSPHATE)
Health Canada record
| Active ingredient(s) | TILMICOSIN (TILMICOSIN PHOSPHATE) 250 MG |
|---|---|
| Dosage form | Solution |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 01-Aug-2021 |
| Current status date | 01-Aug-2021 |
| Source | Health Canada DPD |
Establishment licence of the holder
Modern Veterinary Therapeutics Inc — licence 3-002686, currently licensed, last inspection rating I (2026-07-08).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing TILMICOSIN (TILMICOSIN PHOSPHATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02240124 | PULMOTIL PREMIX | ELANCO CANADA LIMITED | Drug Premix | TILMICOSIN (TILMICOSIN PHOSPHATE) 200 G | Marketed |
| 02461099 | TILMICOSIN 200 | BIO AGRI MIX LP | Drug Premix | TILMICOSIN (TILMICOSIN PHOSPHATE) 200 G | Marketed |
| 02482150 | TILMICOSIN AC | BIO AGRI MIX LP | Solution | TILMICOSIN (TILMICOSIN PHOSPHATE) 250 MG | Approved |
| 02349507 | TILMOVET PREMIX | HUVEPHARMA EOOD | Drug Premix | TILMICOSIN (TILMICOSIN PHOSPHATE) 200 G | Marketed |
| 02393638 | PULMOTIL AC | ELANCO CANADA LIMITED | Solution | TILMICOSIN (TILMICOSIN PHOSPHATE) 250 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 25478 | 2021-03-22 | Abbreviated New Drug Submission (ANDS) |